Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06967051

The Efficacy of a Smart Phone-based Test on Measuring Pupillary Light Reflex Alterations Following Cannabis Use Healthy in Adults

An Open Label Pilot Study Evaluating the Efficacy of a Smart Phone-based Test on Measuring Pupillary Light Reflex Alterations Following Cannabis Use Healthy in Adults

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Sobereye Inc. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

The goal of this open label study is to evaluate the efficacy of smart phone-based test (SOBEREYE OPTOVERA) on measuring pupillary light reflex (PLR) alterations following cannabis use healthy in adults. The main question it aims to answer is: Can SOBEREYE OPTOVERA detect PLR alterations following cannabis consumption in healthy adults, in comparison to a pupillometer? Participants will be given two 5 mg capsules to be ingested for the 10 mg THC dose or five 5 mg capsules to be ingested for the 25 mg THC. Participants will be asked to complete PLR tests throughout the study day.

Conditions

Interventions

TypeNameDescription
DRUGTetrahydrocannabinol (10 mg)10 mg of Tetrahydrocannabinol (THC) provided as a softgel capsule
DRUGTetrahydrocannabinol (25 mg)25 mg of THC provided as a softgel capsule.
DIAGNOSTIC_TESTPupillary Light Reflex (PLR) TestSOBEREYE OPTOVERA is a portable, non-invasive test that measures the Pupillary Light Reflex (PLR)
DIAGNOSTIC_TESTPupillometerNeuroLight is an automated pupillometer that generates a flash of light and measures the photomotor reflex very accurately.

Timeline

Start date
2025-05-22
Primary completion
2025-08-01
Completion
2025-08-01
First posted
2025-05-13
Last updated
2025-07-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06967051. Inclusion in this directory is not an endorsement.